Uloric (febuxostat) ya yarda da FDA a ranar 13 ga Fabrairun 2009. Uloric shine sabon sabon magani a cikin shekaru 40 ga marasa lafiya da ke da hyperuricemia da gout, a cewar Takeda Pharmaceuticals North America, Inc.
Uloric wani magani ne wanda ake amfani dashi don sarrafawa na hyperuricemia a cikin gout. Uloric yana rage yawan kwayoyin cutar uric acid ta hanyar hana xanthine oxidase - wanda ke da alhakin aikin samar da acid uric acid.
Xanthine oxidase ya rushe hypoxanthine (wani abu mai tsabta mai tsabta na halitta) zuwa xanthine, sannan kuma zuwa uric acid.
Ta yaya ake amfani da Uloric?
Aikace-aikacen Uloric da aka amince sun kasance 40 MG da 80 MG da za a ba su kowace rana. Uloric magani ne mai mahimmanci (dauke da baki). Amfanin shawarar farko na Uloric shine 40 MG sau ɗaya a kowace rana. An kara zuwa 80 MG da aka bada shawarar ga marasa lafiya wanda ba su cimma wani magani uric acid na kasa da 6 MG / dL bayan mako biyu a kan 40 mg kashi. Za a iya amfani da Uloric tare da ko ba tare da abinci ba kuma babu wasu shawarwari da suka hana yin amfani da antacids. Babu buƙatar gyaran gyare-gyaren da ake bukata a marasa lafiya waɗanda suke da nakasa ko rashin lafiya.
Ayyuka a cikin gwaji na Clinical
A gwaje-gwaje na asibiti, Uloric ya samo mafi girma fiye da placebo ko samfurin allopurinol - wasu maganin da ake amfani dasu don maganin hyperuricemia. Har ila yau, a cikin watanni 6 na watanni uku-gwaji-yawan adadin marasa lafiya, wadanda suka rage yawan nauyin rukicin acid zuwa matakan da ake bukata a kasa da 6, yafi mafi girma ga wadanda ke dauke da MG 80 maimakon waɗanda ke shan 40 MG na Uloric.
Hanyoyi na gefe da Gargadi
Uloric ba a ba da shawarar ga mutanen dake da hyperuricemia asymptomatic. Uloric ba kamata a yi amfani dasu da mutane da aka riga an bi da su tare da azathioprine (Imuran), mercaptopurine, da theophylline.
Bisa ga uku da aka bazu, nazarin binciken asibiti, ciwon hanta aiki , tashin zuciya, arthralgia, da rash sune mafi halayen halayen da ke faruwa a cikin akalla 1% na marasa lafiya da aka bi da Uloric da akalla 0.5% fiye da placebo.
Har ila yau, idan aka kwatanta da allopurinol, Uloric ya hade da haɗari mafi girma na al'amuran thromboembolic zuciya, amma ba a gano dangantaka ta hanyar kai tsaye ba. Ayyukan haɓaka na hawan gwiwar sune abin da ya fi dacewa da shi wanda ya haifar da ƙarewar Uloric.
Akwai rahotanni na rahotanni na rashin lafiya na rashin lafiya, rashin lafiya da marasa lafiya, a cikin marasa lafiya da aka bi da Uloric. Rahotanni ba su da isasshen bayanai don tabbatar da dalilin da ya faru ba.
An karuwa a cikin gout flares ne sau da yawa samu lokacin da anti-hyperuricemic jamiái da aka fara. Wannan ya hada da Uloric. Idan fitilar gout din da aka hade tare da farawa da maganin Uloric ya faru, ba a buƙatar yin amfani da miyagun ƙwayoyi ba. Don hana ƙwayar gout da ke hade da farawa na maganin Uloric, za'a iya daukar NSAID ko colchicine a lokaci guda. An karu da karuwa a cikin gout flares don rage yawan kwayoyin cutar uric acid wanda, a bi da bi, ke haifar da motsi daga uran nama.
Babu wani nazari mai kyau game da Uloric a cikin mata masu ciki. A lokacin yin ciki, Uloric ya kamata a yi amfani da ita kawai idan amfanin da aka yi tsammani ya fi na haɗari ga tayin. Har ila yau, ba a sani ba idan Uloric ya ragu a madarar mutum.
Dole ne mata masu kula da yara su kasance masu hankali.
Tsarancin Uloric a cikin yara a karkashin shekara 18 ba a san su ba.
Sources:
Uloric ya bayyana Bayanan. Uloric.com. Takeda Pharmaceuticals Inc. Revised Maris 2013.
FDA ta amince da ULORIC® (mai yiwuwa) don Gudanar da Gwaninta na Hyperuricemia a cikin marasa lafiya tare da Gout. Takeda Pharmaceuticals. Fabrairu 13, 2009.